Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib-Reference-Cited by-同舟云学术

Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib

Published:2015-11-12 Issue:1 Volume:108 Page:
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Wong Victor,Pavlick Dean,Brennan Tim,Yelensky Roman,Crawford John,Ross Jeffrey S.,Miller Vincent A.,Malicki Denise,Stephens Philip J.,Ali Siraj M.,Ahn Hyunah

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/108/1/djv307/17986559/djv307.pdf

Reference9 articles.

1. Infantile fibrosarcoma: management based on the European experience;J Clin Oncol Off J Am Soc Clin Oncol,2010

2. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma;Nat Genetics,1998

3. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma;Am J Pathol,1998

4. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues;Am J Clin Pathol,2001

5. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing;Nat Biotechnol,2013

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EMA-Positive Superficial ALK–Rearranged Myxoid Spindle Cell Neoplasm Masquerading as Perineurioma/Hybrid Nerve Sheath Tumor;The American Journal of Dermatopathology;2024-05-07

2. Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing;Translational Pediatrics;2024-04

3. Functional Classification of Fusion Proteins in Sarcoma;Cancers;2024-03-29

4. Safety of current treatment options for NTRK fusion-positive cancers;Expert Opinion on Drug Safety;2023-10-31

5. Progressive insights into fibrosarcoma diagnosis and treatment: leveraging fusion genes for advancements;Frontiers in Cell and Developmental Biology;2023-10-18